Thursday, November 27, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Remain Bullish on Vertex with Price Target Increases

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On March 2, 2024, JMP Securities analyst Joe Goodwin reiterated a Market Outperform rating on Vertex (NASDAQ: VERX) and increased the price target to $42. This adjustment comes after JMP Securities raised the price target on Vertex to $42.00 from $31.00.

Financial groups like Jefferies Financial Group and Citigroup have also revised their price targets on Vertex, reflecting different perspectives on the company’s performance. Overall, analysts have given Vertex an average Outperform rating, with price targets ranging from $27 to $45.

JMP Securities’ positive outlook aligns with other analysts who see potential in Vertex. Analyst Patrick Walravens recently gave Vertex a Buy rating with a price target of $42.00.

VERX Stock Analysis: Strong Long-Term Performance but Short-Term Volatility Ahead

On March 2, 2024, VERX stock closed at $33.55, near the top of its 52-week range and above its 200-day simple moving average, indicating strong long-term performance. However, the price decreased by $0.03 or 0.09% since the previous market close, possibly due to various factors such as market conditions, investor sentiment, or company-specific news. In after-hours trading, the stock dropped by $0.34, raising concerns about ongoing selling pressure. Investors should monitor VERX stock closely in the coming days to see if the downward trend continues or if the stock rebounds. Factors like company earnings reports, market conditions, and industry trends can impact the stock’s performance. Despite its long-term strength, recent price drops suggest short-term volatility, so investors should conduct thorough research and consider their risk tolerance before making investment decisions related to VERX stock.

VERX Stock Performance Analysis: Revenue Up, Net Income Mixed on March 2, 2024

On March 2, 2024, VERX stock had mixed performances based on the financial data provided by CNN Money. The total revenue for the company was $572.39 million for the past year, which represented a 16.43% increase compared to the previous year. However, the total revenue for the fourth quarter was $154.91 million, which remained flat compared to the previous quarter.

The net income for VERX was -$13.09 million for the past year, showing a decrease of 6.41% compared to the previous year. However, the net income for the fourth quarter was $15.33 million, which represented a significant increase of 551.13% compared to the previous quarter.

Earnings per share (EPS) for VERX was -$0.09 for the past year, showing a decrease of 4.87% compared to the previous year. The EPS for the fourth quarter was $0.09, which remained flat compared to the previous quarter.

Overall, VERX stock had a mixed performance on March 2, 2024. While the total revenue showed a significant increase compared to the previous year, the net income and earnings per share had mixed results with decreases in the past year but significant increases in the fourth quarter. Investors should closely monitor the company’s financial performance and market trends to make informed decisions regarding VERX stock.

Tags: VERX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Trading online

Challenges and Opportunities The Story of Gritstone Bio

Finance_ Chart Down

Citigroup Analyst Reiterates Sell Rating on Best Buy Co with Increased Price Target

Finances (2)

Analyst Recommendations and Price Targets for Argenx NASDAQ ARGX

Recommended

Rapid Micro Biosystems Stock

Rapid Micro Biosystems Stock: A Surprising Rally Defies Fundamentals

3 months ago
Ideaya Biosciences Stock

A New Oncology Contender Emerges with Promising Pipeline

1 month ago

Kforce NASDAQ KFRC Reports Strong Quarterly Earnings and Sales Decline

2 years ago
Henry Stock

Rewriting the Rules of Customer Loyalty: Jack Henry’s Stock-Based Rewards Strategy

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

IonQ Shares Draw Major Institutional Investment Amid Mixed Signals

Can Origin Materials Stock Recover From Its Steep Decline?

Iron Mountain Stock: A Battle Between Fundamentals and Market Fears

Karyopharm Shares Face Critical Technical Breakdown

AppLovin Stock: A Clash of Titans in the AI Arena

QuantumScape Leadership Sells Holdings Amid Analyst Optimism

Trending

MSCI World ETF Stock
ETF

The MSCI World ETF’s American Concentration: A Double-Edged Sword for Investors

by Felix Baarz
November 27, 2025
0

The iShares MSCI World ETF (URTH) is often considered a foundational holding for a diversified portfolio. However,...

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

November 27, 2025
Intel Stock

Intel Faces Escalating Industrial Espionage Allegations from TSMC

November 27, 2025
IonQ Stock

IonQ Shares Draw Major Institutional Investment Amid Mixed Signals

November 27, 2025
Origin Materials Stock

Can Origin Materials Stock Recover From Its Steep Decline?

November 27, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • The MSCI World ETF’s American Concentration: A Double-Edged Sword for Investors
  • Gold Nears Historic Peak as Market Anticipation Builds
  • Intel Faces Escalating Industrial Espionage Allegations from TSMC

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com